These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33655342)

  • 1. Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone.
    Distaso E; Milella G; Mezzapesa DM; Introna A; D'Errico E; Fraddosio A; Zoccolella S; Dicuonzo F; Simone IL
    J Neurol; 2021 Sep; 268(9):3307-3315. PubMed ID: 33655342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis.
    Spinelli EG; Riva N; Rancoita PMV; Schito P; Doretti A; Poletti B; Di Serio C; Silani V; Filippi M; Agosta F
    Neuroimage Clin; 2020; 27():102315. PubMed ID: 32593977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study.
    Rajagopalan V; Pioro EP
    Neuroimage Clin; 2017; 14():574-579. PubMed ID: 28337412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional underpinnings of precentral abnormalities in amyotrophic lateral sclerosis.
    Cheng L; Yuan Y; Tang X; Zhou Y; Luo C; Liu D; Zhang Y; Zhang J
    Eur J Neurol; 2021 May; 28(5):1528-1536. PubMed ID: 33404153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional alterations in cortical thickness and white matter integrity in amyotrophic lateral sclerosis.
    Zhang J; Yin X; Zhao L; Evans AC; Song L; Xie B; Li H; Luo C; Wang J
    J Neurol; 2014 Feb; 261(2):412-21. PubMed ID: 24452838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered white matter microarchitecture in amyotrophic lateral sclerosis: A voxel-based meta-analysis of diffusion tensor imaging.
    Zhang F; Chen G; He M; Dai J; Shang H; Gong Q; Jia Z
    Neuroimage Clin; 2018; 19():122-129. PubMed ID: 30035009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precentral degeneration and cerebellar compensation in amyotrophic lateral sclerosis: A multimodal MRI analysis.
    Qiu T; Zhang Y; Tang X; Liu X; Wang Y; Zhou C; Luo C; Zhang J
    Hum Brain Mapp; 2019 Aug; 40(12):3464-3474. PubMed ID: 31020731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
    Witzel S; Maier A; Steinbach R; Grosskreutz J; Koch JC; Sarikidi A; Petri S; Günther R; Wolf J; Hermann A; Prudlo J; Cordts I; Lingor P; Löscher WN; Kohl Z; Hagenacker T; Ruckes C; Koch B; Spittel S; Günther K; Michels S; Dorst J; Meyer T; Ludolph AC;
    JAMA Neurol; 2022 Feb; 79(2):121-130. PubMed ID: 35006266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis.
    Christidi F; Karavasilis E; Riederer F; Zalonis I; Ferentinos P; Velonakis G; Xirou S; Rentzos M; Argiropoulos G; Zouvelou V; Zambelis T; Athanasakos A; Toulas P; Vadikolias K; Efstathopoulos E; Kollias S; Karandreas N; Kelekis N; Evdokimidis I
    Brain Imaging Behav; 2018 Apr; 12(2):547-563. PubMed ID: 28425061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System.
    Vu M; Tortorice K; Zacher J; Dong D; Hur K; Zhang R; Good CB; Glassman PA; Cunningham FE
    JAMA Netw Open; 2020 Oct; 3(10):e2014645. PubMed ID: 33017028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis.
    Roccatagliata L; Bonzano L; Mancardi G; Canepa C; Caponnetto C
    Amyotroph Lateral Scler; 2009 Feb; 10(1):47-52. PubMed ID: 18622772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical Thinning Pattern of Bulbar- and Spinal-onset Amyotrophic Lateral Sclerosis: a Surface-based Morphometry Study.
    Chen ZY; Liu MQ; Ma L
    Chin Med Sci J; 2018 Jun; 33(2):100-106. PubMed ID: 29976279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural MRI correlates of amyotrophic lateral sclerosis progression.
    Senda J; Atsuta N; Watanabe H; Bagarinao E; Imai K; Yokoi D; Riku Y; Masuda M; Nakamura R; Watanabe H; Ito M; Katsuno M; Naganawa S; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):901-907. PubMed ID: 28501822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis.
    Borsodi F; Culea V; Langkammer C; Khalil M; Pirpamer L; Quasthoff S; Enzinger C; Schmidt R; Fazekas F; Ropele S
    PLoS One; 2017; 12(6):e0178371. PubMed ID: 28575122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis.
    Valsasina P; Agosta F; Benedetti B; Caputo D; Perini M; Salvi F; Prelle A; Filippi M
    J Neurol Neurosurg Psychiatry; 2007 May; 78(5):480-4. PubMed ID: 17030586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration.
    Bede P; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):232-241. PubMed ID: 29214883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation.
    Iwata NK; Aoki S; Okabe S; Arai N; Terao Y; Kwak S; Abe O; Kanazawa I; Tsuji S; Ugawa Y
    Neurology; 2008 Feb; 70(7):528-32. PubMed ID: 18268244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
    Lombardo F; Frijia F; Bongioanni P; Canapicchi R; Minichilli F; Bianchi F; Hlavata H; Rossi B; Montanaro D
    Arch Ital Biol; 2009 Sep; 147(3):69-82. PubMed ID: 20014653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Value of Multimodal Magnetic Resonance Imaging in Disease Progression of Amyotrophic Lateral Sclerosis: A Prospective Observational Study.
    Shen DC; Xu YY; Hou B; Tai HF; Zhang K; Liu SW; Wang ZL; Feng F; Liu MS; Cui LY
    Chin Med J (Engl); 2018 Dec; 131(24):2904-2909. PubMed ID: 30539901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk.
    Menke RA; Proudfoot M; Wuu J; Andersen PM; Talbot K; Benatar M; Turner MR
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):580-8. PubMed ID: 26733601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.